In the year 2023, the global pancreatic cancer market is poised to achieve a valuation of approximately US$ 2,125.57 Million, exhibiting a noteworthy growth trajectory. Anticipated to surge at a robust Compound Annual Growth Rate (CAGR) of 13.5%, this market is on track to surpass the US$ 7,541.09 Million mark by 2033. Pancreatic cancer, a …